Ray Dalio’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-145,801
Closed -$6.06M 1044
2025
Q4
$6.06M Sell
145,801
-18,537
-11% -$752K 0.02% 473
2025
Q3
$7.58M Buy
164,338
+21,488
+15% +$1.15M 0.03% 388
2025
Q2
$7.55M Buy
142,850
+81,068
+131% +$4.28M 0.03% 291
2025
Q1
$3.44M Buy
+61,782
New +$2.96M 0.02% 403
2024
Q4
Sell
-9,317
Closed -$477K 723
2024
Q3
$477K Sell
9,317
-11,115
-54% -$744K ﹤0.01% 693
2024
Q2
$1.29M Buy
+20,432
New +$1.23M 0.01% 619
2024
Q1
Sell
-9,024
Closed -$886K 714
2023
Q4
$886K Buy
+9,024
New +$786K 0.01% 649

Other funds holding CNXC

Ray Dalio's CNXC Position: Q1 2026 in Review

Ray Dalio sold out of Concentrix (CNXC) in Q1 2026, closing a stake of 145,801 shares — an estimated $6.06M sold.

Ray Dalio first reported a position in CNXC in Q4 2023 and held it in 7 quarters. The position peaked at $7.58M in Q3 2025. 302 funds tracked by Wall St. Rank hold CNXC as of Q1 2026.

  • Ray Dalio reported no remaining Concentrix position as of Q1 2026 after selling out during the quarter.
  • Ray Dalio sold 145,801 Concentrix shares in Q1 2026, an estimated $6.06M.
  • Ray Dalio first reported a position in Concentrix in Q4 2023 and held it in 7 quarters.
  • Ray Dalio's Concentrix position peaked at $7.58M in Q3 2025.
  • 302 funds tracked by Wall St. Rank held Concentrix as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.